Kimball Electronics (KE) 2026 KeyBanc Capital Markets Healthcare Forum summary

Company overview and strategic focus

• Operates in automotive, industrial (green and clean), and medical verticals, with a global footprint across North America, Asia, and Europe.

• Recent strategic shift toward healthcare and medical end markets, leveraging electronics and plastics molding capabilities.

• Opened a state-of-the-art CMO facility in Indianapolis, focusing on full medical device assembly and drug delivery systems.

• Facility features include cold chain, Class 7/8 clean rooms, and design labs, supporting growth and customer requirements.

• Pursues both organic investment and inorganic (M&A) strategies to expand capabilities and geographic reach.

Competitive strengths and differentiation

• Offers full and final assembly for medical customers, including design for manufacturing and volume production.

• Vertical integration enables production of complex devices like auto-injectors with embedded electronics and audio prompts.

• Expertise in miniaturization and portable diagnostic devices aligns with market trends.

• Single SAP instance across most facilities enhances global customer support and operational efficiency.

Financial performance and outlook

• Medical segment achieved 15% growth in Q2, driven by broad-based gains across geographies and customers.

• Automotive segment stabilized after a major program loss, with expectations for flat or slightly increased performance.

• Industrial segment saw softness in climate control, but is expected to flatten and rebound.

• Raised full-year revenue guidance by $25–$30 million to $1.4 billion, with adjusted income margin guidance increased to 4.2%-4.5%.

• Gross margin improvement attributed to cost discipline, facility consolidation, and asset divestitures.